Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor
- 12 August 2014
- journal article
- Published by Wiley in Haemophilia
- Vol. 20 (5), e372-e375
- https://doi.org/10.1111/hae.12519
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Hereditary Angioedema with Normal C1 InhibitorImmunology and Allergy Clinics of North America, 2013
- Novel duplication in the F12 gene in a patient with recurrent angioedemaClinical Immunology, 2013
- Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunitiesBlood, 2013
- A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitorClinical Immunology, 2011
- Hereditary angioedema caused by missense mutations in the factor XII gene: Clinical features, trigger factors, and therapyJournal of Allergy and Clinical Immunology, 2009
- Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type IIIAmerican Journal of Human Genetics, 2006
- Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitorBiochemical and Biophysical Research Communications, 2006
- Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XIIProceedings of the National Academy of Sciences, 2002
- Hereditary angioedema with normal C1-inhibitor activity in womenThe Lancet, 2000
- [4] Factor XII: Hageman factorMethods in Enzymology, 1993